A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). Pfizer, GSK and Shionogi have all signed on to sponsor the upcoming London run of the stage ...
Pfizer said it would acquire weight loss biotech Metsera in a deal valued at up to $7.3 billion, including future payments, as it scrambles to win a slice in the booming obesity drug market. The move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results